Kymeta Launches First Flat Panel Antenna for Maritime Industry on OneWeb’s LEO Network
World-leading flat panel satellite antenna company Kymeta (www.kymetacorp.com) and low Earth orbit (LEO) satellite communications company OneWeb (oneweb.net) today announced that Kymeta’s electronically steered Peregrine u8 LEO terminal is now commercially available, becoming the first flat panel antenna to serve the maritime market on OneWeb’s LEO network.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230606005230/en/
Kymeta's electronically steered Peregrine u8 LEO terminal. (Photo: Business Wire)
This industry-first offering unlocks a new standard of connectivity for maritime customers who require exceptional performance and reliable connectivity at sea where existing networks often don’t reach. Kymeta’s deep roots in the maritime market extend back to the launch of its maritime product line in 2017 and guided the streamlined design of the Peregrine u8 LEO terminal, which is purpose-built for maritime applications. By tapping into OneWeb’s enterprise-grade connectivity, all large vessels – from super yachts to commercial fishing and shipping vessels – can now connect easily and seamlessly at sea as they would on land.
“Our maritime customers have a unique set of needs, whether that be reliable cyber-security and access to real-time maintenance or connecting to the cloud and streaming their favorite show. That’s why we’ve made it our mission to develop an equally unique solution,” said Walter Berger, President and Co-CEO, Kymeta. “As a proud partner of OneWeb, today marks an exciting day for Kymeta because it represents the fulfillment of our joint commitment to bring to market a low-power, low-profile LEO terminal, built to elevate and modernize maritime communications.”
Carole Plessy, VP Maritime and Europe at OneWeb added, “By harnessing the power of our constellation of LEO satellites, the Peregrine u8 from Kymeta will enable mobile connectivity at sea, on multiple devices in the same way as the home network in your living room. We are thrilled by today’s milestone in our partnership with Kymeta, as it’s proof of our collective leadership in advancement of the satellite industry and an acknowledgement that connectivity should be readily accessible, regardless of where you are or where you’re going.”
Traditional maritime antennas are bulky, requiring high power and below-deck hardware. In contrast, Kymeta’s slim, energy-efficient Peregrine u8 requires no specialized installation equipment and can be installed onboard by just two people within hours, rather than days.
Attendees of the upcoming Nor-Shipping event in Oslo, Norway on June 6-8 are encouraged to stop by OneWeb’s booth (stand number B03-14) to see the Peregrine u8 in person and to speak with a member of Kymeta’s team.
About Kymeta
Kymeta is the industry leader in flat panel satellite antennas, providing purpose-built solutions across a variety of enterprise and military applications and unlocking the commercial value of space to address the vast, unmet demand for ubiquitous broadband and truly mobile connectivity for customers around the world. Its innovative metasurface technology, coupled with a software-first approach, delivers the first commercially available, metamaterial-based and electronically steered flat panel satellite antenna. Kymeta’s low-cost, low-power and high throughput solutions make it easy to connect on the move or while stationary – for any vehicle, vessel, aircraft, or fixed platform – enabling industries on earth to transform their operations by harnessing capacity in space.
Kymeta is a privately held company based in Redmond, Washington.
For more information, visit kymetacorp.com
About OneWeb
OneWeb is a global communications network powered from space, enabling connectivity for governments, businesses, and communities. It is implementing a constellation of low Earth orbit (LEO) satellites with a network of global gateway stations and a range of user terminals to provide an affordable, fast, high-bandwidth and low-latency communications service, connected to the IoT future and a pathway to 5G.
Find out more at http://www.oneweb.world
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230606005230/en/
Contact information
Business Inquiries for Kymeta:
Brenda Kuhns
Senior Director of Marketing
Kymeta Corporation
bkuhns@kymetacorp.com
Media Inquiries for Kymeta:
Katie Rolnick
Senior Account Executive
Revere
Katie.Rolnick@revereteam.com
Media Inquiries for OneWeb:
Tabitha Aldrich-Smith / Katie Dowd
taldrich-smith@oneweb.net / kdowd@oneweb.net
FGS Global
OneWeb-LON@fgsglobal.com
About Business Wire
Business Wire(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Kinaxis Positioned Highest on Ability to Execute in the Gartner® Magic Quadrant™ for Supply Chain Planning Solutions26.4.2024 18:03:00 CEST | Press release
Kinaxis® Inc. (TSX:KXS), a global leader in end-to-end supply chain orchestration, today announced it has been named a Leader in the 2024 Gartner® Magic Quadrant™ for Supply Chain Planning Solutions. Of the 20 vendors evaluated, Gartner positioned Kinaxis highest on Ability to Execute, marking the company’s 10th consecutive Leaders Quadrant within the report, a complimentary copy of which can be downloaded here. Kinaxis attributes its position to its patented concurrency approach and a proven track record of delivering innovative solutions against the foundation of its leading vision through the use of advanced technology such as AI, ML, and an intuitive user experience. Bolstered by a rich ecosystem of third-party implementation partners, Kinaxis continues to demonstrate that regardless of a customer’s industry, size, or maturity level, the company can be counted on to seamlessly orchestrate supply chain networks end-to-end from strategic planning to last-mile delivery. The recognitio
Vertex Announces European Commission Approval for KALYDECO ® to Treat Infants With Cystic Fibrosis Ages 1 Month and Older26.4.2024 17:43:00 CEST | Press release
Vertex Pharmaceuticals (Nasdaq: VRTX) today announced that the European Commission has granted approval for the label expansion of KALYDECO® (ivacaftor) for the treatment of infants down to 1 month of age with cystic fibrosis (CF) who have one of the following mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene: R117H, G551D, G1244E, G1349D, G178R, G551S, S1251N, S1255P, S549N or S549R. “Today’s approval is an important milestone for the cystic fibrosis community. Treating CF early in life can potentially slow the progression of the disease, which is why it is so important to start treatment from a very young age,” said Carmen Bozic, M.D., Executive Vice President, Global Medicines Development and Medical Affairs, and Chief Medical Officer, Vertex. As a result of existing access agreements in Austria, Czech Republic, Denmark, Ireland, Norway, Sweden, and The Netherlands, eligible patients will have access to the expanded indication of KALYDECO® (ivacaftor)
Suzano 2023 annual report on Form 20-F26.4.2024 17:22:00 CEST | Press release
Suzano S.A. (B3: SUZB3 | NYSE: SUZ) informs that its 2023 Annual Report on Form 20-F was filed today with the U.S. Securities and Exchange Commission. Holders of the Company’s equity securities can receive hard copies of the Annual Report, including its audited financial statements, without charge by request directed to: ri@suzano.com.br. This document is also available on Suzano’s website (http://ir.suzano.com.br/). For further information, please contact our Investor Relations Department: Phone: (+55 11) 3503-9330 E-mail: ri@suzano.com.br View source version on businesswire.com: https://www.businesswire.com/news/home/20240426289818/en/Contact information Hawthorn Advisors suzano@hawthornadvisors.com
Takeda Receives Positive CHMP Opinion for Fruquintinib in Previously Treated Metastatic Colorectal Cancer26.4.2024 14:30:00 CEST | Press release
Takeda (TSE:4502/NYSE:TAK) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of fruquintinib, a selective inhibitor of vascular endothelial growth factor receptors (VEGFR) -1, -2 and -3 for the treatment of adult patients with previously treated metastatic colorectal cancer (mCRC). The European Commission (EC) will consider the CHMP positive opinion when determining the potential marketing authorization for fruquintinib for mCRC throughout the European Union (EU), Norway, Liechtenstein and Iceland. If approved, fruquintinib will be the first and only selective inhibitor of all three VEGF receptors approved in the EU for previously treated mCRC.1,2 “People living with metastatic colorectal cancer in the European Union currently have limited treatment options, which can lead to poor outcomes. With this positive opinion for fruquintinib, we are one step closer to potentially offering patients a new
MEDIA ALERT: Wolters Kluwer expert comments on European Parliament vote to pass amendment implementing Basel III reforms26.4.2024 14:00:00 CEST | Press release
The European financial landscape saw a milestone event this week, as the EU Parliament passed the Amendment to Regulation (EU) No 575/2013, implementing the Basel III finalization within Europe. This monumental step forward comes with the adoption of the Capital Requirements Regulation (CRR3) amendments, which are part of a broader legislative package, including amendments to Directive 2013/36/EU, known as the Capital Requirements Directive or CRD. Jeroen Van Doorsselaere, Vice President of Global Product & Platform Management, Wolters Kluwer FRR, said: “The adoption of the Capital Requirements Regulation (CRR3) amendments represents a landmark change for the banking industry, designed to strengthen the framework for risk-based capital requirements and address ESG risks. “This is a major overhaul of the capital requirements framework, impacting various aspects, including credit risk, operational risk, market risk, and the capital floor. Whereas other significant jurisdictions, includin